A non-interventional, observational, cross-sectional study to assess the impact of Parkinson's disease on quality of life of Parkinson's disease patients and their caregivers in Japan.

Not Applicable

• Conditions: s disease; Parkinson&#39

• Registration Number: JPRN-UMIN000028490
• Lead Sponsor: AbbVie GK

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-08-14
• Study Completion: 2017-10-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

Not provided

Exclusion Criteria

Information from caregivers of patients who have not provided informed consent will not be included.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is PDQ-8 summary index score, PDQ-8 SI. The primary indicator of PD severity is off-time period per day. The secondary indicators of PD severity are original H&Y stage, presence of wearing-off (WOQ-9 score), troublesome dyskinesia period per day, motor symptoms (SE-ADL score) and NMS (NMSQ total score).

Secondary Outcome Measures

Name	Time	Method
The secondary endpoints are as follows: - EQ-5D-5L index value - PDQ-carer summary index, PDQ-carer SI